ROXITRAC 150 Tablet

Tough Power that Delivers Results

COMPOSITION: Roxithromycin IP 150 mg

Indication :

  • Rheumatoid Arthritis
  • ENT infections
  • Pneumonia
  • Genitourinary tract infection
  • Skin infection


COMPOSITION: Roxithromycin IP 150 mg


Drug class: Macrolides 

  • Roxithromycin is a derivative of the macrolide antibacterial erythromycin with in vitro antibacterial activity resembling that of the parent compound.
  • As effective as more established treatments including erythromycin, amoxicillin/clavulanic acid and cefaclor.
  • In vivo, roxithromycin is as effective or more effective than other macrolides in a wide range of infections.
  • It is active against gram-positive and gram-negative cocci, gram-positive bacilli and some gram-negative bacilli, but has no significant effect on the predominant faecal flora.
  • It also displays good activity against atypical pathogens, such as Mycobacterium avium complex, Helicobacter pylori and Borrelia spp.
  • Roxithromycin significantly improved the signs and symptoms (in 3 months) of rheumatoid arthritis in adult patients and was generally well tolerated.